Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
CCTV 315 Exposes Private Domain Marketing Schemes: Fabricating Fake Courses and Lectures, Selling Overpriced Drugs to Defraud Seniors
According to the CCTV 315 Night Show report, in late January 2026, an internal industry exchange meeting for private domain marketing was held in a certain city in Central China, with over a hundred related companies participating. During the event, many company representatives took the stage to speak and seek partners.
At the scene, the so-called “online video production companies” are a key part of the private domain marketing industry. These “online video producers” select products from pharmaceutical or health supplement companies, then produce a series of videos such as health lectures based on the purchased products—ranging from four or five episodes to hundreds. After the programs are completed, the “video producers” bundle the products and programs and sell them to private domain marketing firms. These firms then use various methods to attract customers, guiding consumers to social platform private scenes where courses are played for product marketing.
The medicines and health supplements purchased by these video producers are very inexpensive, but they are sold externally at very high prices. Over the past year, the State Market Supervision Administration has taken serious action against scams and frauds in the private domain sector targeting the elderly.
A company called “Da Hong International,” a video production firm, currently promotes a video series called “Life Code” in the private domain sector. According to marketing materials sent by Manager Liu from Da Hong International, the first round of 20 episodes of this product video has been completed, and the second round has reached episode 15. The main product promoted is an OTC medicine called “Huoyuan Tai Ganlu Graft Peptide Oral Solution,” priced at 298 yuan per box, with a 90ml specification.
The materials describe “Life Code” as a course based on the “21st Century’s First Therapy—Cell Regeneration Therapy.” It claims that by taking “Huoyuan Tai Ganlu Graft Peptide Oral Solution,” patients with various stubborn diseases can recover.
These diseases—cataracts, hypertension, heart failure, heart attacks, strokes—are difficult to treat with current modern medicine. In the “Life Code” videos, an expert claims that patients only need to take “Huoyuan Tai,” and these complex illnesses can be easily cured. Is this medicine truly so miraculous? Searching online reveals information about the indications for “Huoyuan Tai Ganlu Graft Peptide Oral Solution,” and the answer is shocking.
The indications for this medicine are for immune deficiency, recurrent respiratory infections, leukopenia, aplastic anemia, and as an adjunct in tumor treatment—aimed at alleviating adverse effects of radiotherapy and chemotherapy on hematopoietic and gastrointestinal systems.
The indications listed for “Huoyuan Tai Ganlu Graft Peptide Oral Solution” are severely inconsistent with the exaggerated claims promoted in the “Life Code” videos. What is the real value of this product? Further searches found no market price for the 90ml specification of “Huoyuan Tai Ganlu Graft Peptide Oral Solution,” but another product with the same manufacturer, approval number, and drug code—“Ganlu Graft Peptide Oral Solution (An Jia An)” in 100ml—has a market price of only 68 yuan.
A common auxiliary treatment drug is being falsely advertised with exaggerated or altered effects and sold at nearly five times the market price.
According to Manager Liu of Da Hong International, behind every scam targeting elderly consumers in these videos, there is a professional planning company that customizes “scam scripts” for the producers.
Zhong, the general manager of Shengwei Company, said that whether an online video can sell products depends heavily on the “medical experts” featured in the videos. Since experts are so crucial, what kind of people can become the main speakers in these videos?
Zhong admitted that in the past, most of the so-called “experts” in their videos were impostors. Now, with tighter regulation of the private sector industry, they are starting to look for medical personnel with licensed doctor or pharmacist certificates to record programs. However, these medical staff, despite their impressive titles, are still products of company design and packaging. Titles like “Disciples of Traditional Chinese Medicine,” “Society President,” or “Expert Committee Member” are almost all just props that can be bought with money.
For example, take ophthalmologist Ding Yuqiu in the videos. According to records, Ding holds a medical license, but his license shows his practice scope is internal medicine, not ophthalmology. How can an internist suddenly become an “ocular authority” online?
Ding explained that first, you need a medical license; second, you need to speak well. Don’t worry about the “title”—that can be bought. You can pay a fee, join an association, and become a vice president, which is very simple.
Verification on the Ministry of Civil Affairs’ “China Social Organization Government Service Platform” shows no registration record for the “Chinese Medical Doctor Society.” If consumers don’t search carefully online, they would never know that the so-called “Chinese Medical Doctor Society” Ding mentions is a non-existent organization.
(Content summarized from the CCTV 315 Night Show report)
(Edited by: Yang Yan, Lin Chen)
Keywords: Medical